Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22,421,536
-
Total 13F shares
-
19,565,976
-
Share change
-
+7,970,434
-
Total reported value
-
$105,428,086
-
Put/Call ratio
-
68%
-
Price per share
-
$5.39
-
Number of holders
-
93
-
Value change
-
+$42,942,248
-
Number of buys
-
39
-
Number of sells
-
39
Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q3 2025
As of 30 Sep 2025,
CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,565,976 shares.
The largest 10 holders included
GLAZER CAPITAL, LLC, ALPINE ASSOCIATES MANAGEMENT INC., Qube Research & Technologies Ltd, BlackRock, Inc., AQR Arbitrage LLC, WATER ISLAND CAPITAL LLC, Magnetar Financial LLC, ROYAL BANK OF CANADA, Bridgewater Associates, LP, and BANK OF AMERICA CORP /DE/.
This page lists
93
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.